Cavitated tumor as a clinical subentity in squamous cell lung cancer patients

Neoplasma

Volumn 50, Issue 1, 2003, Pages 66-73

  Kolodziejski, L S ^a   Dyczek, S ^a   Duda, K ^a   Goralczyk J ^b   Wysocki, W M ^a   Lobaziewicz, W ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b Pneumonological Hospital   (Poland)

Author keywords

Cavitation; Lung cancer; Prognosis; Squamous cell; Surgery; Survival

Indexed keywords

ADULT; AGED; ARTICLE; ATELECTASIS; BODY MASS; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG CAVITATION; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THORACOTOMY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0037270402     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. American Society of Anesthesiologist: New classification of physical status. Anesthesiology 1963; 24: 111.
2. American Thoracic Society/European Respiratory Society Official Statement: Pretreatment evaluation of non-small cell lung cancer. Am J Respir Crit Care Med 1997; 156: 320-332.
3. BELCHER JR. Thirty years of surgery for carcinoma of the bronchus. Thorax 1983; 38: 428-432.
4. BERNHARD WF, MALCOLM JA, WYLIE RH. The carcinomatous abscess; a clinical paradox. New Engl J Med 1962; 266: 914-919.
5. BIESALSKI HK, MESQUITA B, CHESSON A, CHYTLI F, GRIMBLE R, HERMUS RJJ, KOHRLE J, LOTAN R, NORPOTH K, PASTORINO U, THURNHAM D. European consensus statement on lung cancer. CA Cancer J Clin 1998; 48: 167-176.
6. BRODERICK LS, TRAVER RD, CONCES DJ. Imaging of lung cancer old and new. Semin Oncol 1997; 24: 411-418.
7. BÜLZEBRUCK H, BOPP R, DRINGS P, BAUER E, KRYSA S, PROBST G, VIM KAICK G, MULLER KM, VOGT-MOYKOPF I. New aspect in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification. Cancer 1992; 70: 1102-1110.
8. BÜLZEBRUCK H, KRYSA S, BAUER E, PROBST G, DRINGS P, VOGHTMOYKOPF I. Validation of the TNM classification (4th edition) for lung cancer: first results of a prospective study of 1086 patients with surgical treatment. Eur J Cardiothorac Surg 1991; 5: 356-362.
9. CHAUDCHURI MR. Primary pulmonary cavitating carcinomas. Thorax 1973; 28: 354-366.
10. CHIU FTS. Cavitation in lung cancers. Aust NZ J Med 1975; 5: 523-530.
11. CONILL C, ASTUDILLO J, OTAL JJ. Prognostic value of tumor size in non-oat cell lung carcinoma. Lung Cancer 1988; 4: A58.
12. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972; 34: 187-220.
13. Cox JD. The respective roles of radiation therapy and chemotherapy in non small cell carcinoma of the lung with mediastinal but not distant metastasis (N2M0). Lung Cancer 1991; 7: 65-69.
14. CRUMP M. Postoperative chemotherapy for resected non small cell lung cancer. World J Surg 1993; 17: 735-740.
15. DOBROWOLSKI J, SZYSZKO S. Cavernous lung cancer. Pol Przegl Radiol Med Nukl 1968; 6: 720-727.
16. ESTRERA AS, PLATT MR, MILLS LJ, SHAW RR. Primary lung abscess. J Thorac Cardiovasc Surg 1980; 79: 275-282.
17. FEIGIN MI, GIAURGIEWA OKH, KICHA MG, KNORING BE, KHAEVA SKH, RAPIS IL. Current principles of cavitary formations in the lungs. Probl Tuberk 1992; 7-8: 13-15.
18. FELD RF, ARRIAGADA R, BALL DL, MATTISON K, SORENSEN JB. Prognostic factors in non-small cell lung cancer: a consensus report. Lung Cancer 1991; 7: 3-5.
19. FIELDING LP. The future of prognostic factors in outcome prediction for patients with cancer. Cancer 1992; 70: 2367- 2377.
20. GEDDES DM. The natural history of lung cancer. A review based on rates of tumor growth. Br J Dis Chest 1979; 73: 1-17.
21. GEORGE SL. Identification and assessment of prognostic factors. Semin Oncol 1988; 15: 462-471.
22. GOOD CA, HOLMAN CB. Cavitary carcinoma of the lung, roentgenologic features in 19 cases. Dis Chest 1960; 37: 289-293.
23. HEELAN RT, MARTINI N, WESTCOTT JW, BAINS MS, WATSON RC, CARAVELLI JF, BERKMEN YM, HENSCHKE CI, MCCORMAC PM, MC CAUGHAN BC. Carcinomatous involvement of the hilum and mediastinum: computed tomographic and magnetic resonance evaluation. Radiology 1985; 156: 111-115.
24. HOLMES EC, MITCHELL G, HILL ID, FELD R, GINSBERG R, MOUNTAIN C, GRECO A, EAGAN R. Effects of postoperative mediastinal radiation on completely resected stage II and III epidermoid cancer of the lung. N Engl J Med 1986; 315: 1377-1381.
25. HOLMES EC. Surgical adjuvant therapy of non small cell lung cancer. Lung Cancer 1991; 7: 71-76.
26. ICHINOSE Y, HARA N, OHTA M, YANO T, MAEDA K, ASOH H, KATSUDA Y. Is factor T of the TNM staging system a predominant prognostic factor in pathologic stage I non-small cell lung cancer? A multivariate prognostic factor analysis of 151 patients. J Thorac Cardiovasc Surg 1993; 196: 90-94.
27. INOUE JP, SATO M, FUJIMURA S, SAKURADA A, TAKAHASHI S, USUDA K, KONDO T, TANITA T, HANDA M, SAITO Y, SAGAWA M. Prognostic assessment of 1310 patients with non-small cell lung cancer who underwent complete resection from 1980-1993. J Thorac Cardiovasc Surg 1998; 116: 407-411.
28. IZBICKI JR, THETTER O, HABEKOST M, KARG O, PASSLICK B, KUBUSCHOK B, BUSCH C, HAEUSSINGER K, KNOEFEL WT, PANTEL K, SCHWEIBERER K. Radical systematic lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 1994; 81: 229-235.
29. JI WK. Roentgenodiagnosis of primary lung carcinoma with cavity-analysis of 100 cases. Chung Hua Chung Liu Tsa Chih 1986; 8: 122-124.
30. KADRI MA, DUSSEK JE. Survival and prognosis following resection of primary non-small cell bronchogenic carcinoma. Eur J Cardiothorac Surg 1991; 5: 132-136.
31. KAPLAN EL, MEIER P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
32. KAYSER K, BÜLZEBRUCK H, PROBST G, VOGT-MOYKOPF I. Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients. Cancer 1987; 59: 355-361.
33. KAZEROONI EA, BHALLA M, SHEPARD JO, MCLOUD T. Adenosquamous carcinoma of the lung: radiologic appearance. Am J Roentgenol 1994; 163: 301-306.
34. KOLODZIEJSKI L, DYCZEK S, DUDA K, GORALCZYK J. Comparison of clinical characteristics and results of surgical treatment in patients with squamous cell lung cancer before and after introducing of modern diagnostic methods. Pol Przegl Chir 2002; 74: 113-125.
35. KOLODZIEJSKI L, NIEZABITOWSKI A, GASINSKA A. Clinical and flow cytometric prognostic factors in surgically treated squamous cell lung cancer. Lung Cancer 1997; 16: 173-182.
36. LAUMONIER P, FRECUR P, TESSIER D, COURAUD L. Primary lung cancer. Study of 5-year survival in a series of 305 resections done between 1961-1970. Bull Acad Natl Med (Paris) 1978; 162: 214-218.
37. LAVOIE RR, Mc DONALD JR, KLING GA. Cavitation in squamous carcinoma of the lung. Acta Cytol 1977; 2: 210-214.
38. LONGEFAIT H, HUET R. 5-year survival related to presenting symptoms in 1511 cases of lung cancer. Bronchopneumologie 1977; 27: 231-237.
39. MAKI E, FELD R. Prognostic factors in patients with nonsmall cell lung cancer. A critique of the world literature. Lung Cancer 1991; 7: 27-34.
40. MARTINI N, HEELAN R, WESTCOTT J, BAINS MA, MCCORMACK P, CARAVELLI J, WATSON R, ZAMAN M. Comparative merits of conventional computed tomographic and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg 1985; 90: 639-648.
41. McKNEALLY MF. Lung cancer: a surgeons approach. Curr Probl Surg 1987; 24: 686-757.
42. MEGEVAND R, BRAND U, HUBER O, SPILIOPOULOS A. Survival of surgically-treated lung cancer patients. Actuarial results at 5 years. Schweiz Med Wochenschr 1979; 109: 851-854.
43. MEKO J, RUSCH VW. Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer. Semin Rad Oncol 2000; 4: 324-332.
44. MILLER RR, MCGREGOR DH. Hemorrhage from carcinoma of the lung. Cancer 1980; 46: 200-205.
45. MIURA H, TAIRA O, HIRAGURI S, HAGIWARA M, KATO H. Cavitating adenocarcinoma of the lung. Ann Thorac Cardiovasc Surg 1998; 4: 154-158.
46. MOUNTAIN CF. New prognostic factors in lung cancer. Biologic prophets of cancer aggression. Chest 1995; 108: 246-254.
47. MOUNTAIN CF. Surgical treatment of lung cancer. Clin Rev Oncol/Hematol 1991; 11: 179-207.
48. MOUROUX J, PADOVANI B, ELKAIM D, RICHELME H. Should cavitated broncho-pulmonary cancer be considered a separate entity? Ann Thorac Surg 1996; 61: 530-532.
49. NARUKE T, TSUCHIYA R, KONDO H, NAKAYAMA H, ASAMURA H. Lymph node sampling in lung cancer: how should it be done? Eur J Cardiothorac Surg 1999; Suppl 16: 17-24.
50. OEHY K, VOGT B. Operated bronchial carcinoma: a review of 230 cases. Int Surg 1986; 71: 112-114.
51. PATER J, LOEB M. Nonanatomic prognostic factors in carcinoma of the lung. A multivariate analysis. Cancer 1982; 50: 326-331.
52. PETO R, PIKE MG, ARMITAGE P, BRESLOW NE, Cox DR, HOWARD SV, MANTEL N, MCPHERSON K, PETO J, SMITH PG. Design and analysis on randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1-39.
53. PURTSKHVANIDZE CG, GEORGADZE AS, GIVISHVILI UA. Differential diagnosis of cavitary formation in the lungs of tuberculous and non-tuberculous etiology. Probl Tuberk 1990; 2: 24-26.
54. RATTO GB, FROLA C, CANTONI S, MOTTA G. Improving clinical efficacy of computed tomographic scan in the preoperative assessment of patients with non small cell lung cancer. J Thorac Cardiovasc Surg 1990; 99: 416-425.
55. ROCKMANS P, EMAMI B, COX J, PACAGNELLA A, HOLSTI L, MONTEAN M, HELLE P, CONIS R, SEHAAKE C. Quality control in NSCLC treatment: a consensus report. Lung Cancer 1991; 7: 19-20.
56. SMALLEY KJ, KNERR AN, KENDRICK ZV, COLLIVER JA, OWEN OE. Reassessment of body mass indices. Am J Clin Nutr 1990; 52: 405-408.
57. SONE S, SAKAI F, TAKASHIMA S, HONDA T, YAMACHA T, KUBO K, FUKASAKU K, MARUYAMA K, LI F, HASEGAWA M, ITo A, VANG Z. Factors affecting of the radiologic appearance of peripheral bronchogenic carcinomas. J Thorac Imaging 1997; 12: 159-172.
58. SPASSKAYA PA, MUSHINA LN. Differential roentgenologic diagnosis of solitary cavities in the lungs. Vestn Roentgenol Radiol 1977; 4: 3-10.
59. STRANG C, SIMPSON JA. Carcinomatous abscess of the lung. Thorax 1953; 8: 11-14.
60. SWENSEN SJ, BROWN LR. Conventional radiography of the hilum and mediastinum in bronchogenic carcinoma. Radiol Clin N Amer 1990; 28: 521-538.
61. TAKASHIMA S, MORIMOTO S, IKEZOE J, ARISAWA J, HAMADA S, KOZUKA T. Cavitating malignant neoplasms in the lung. Jpn J Clin Radiol 1989; 34: 45-50 (Eng. abstr).
62. TANIGAWA S, HIROTA T, MORISHASHI M. A study on radiological images of cavitary lung cancer. Nippon Kyobu Rinshou 1991; 50: 831-838.
63. UICC International Union Against Cancer. TNM Classification of malignant tumors. 5-ed New York 1997; 93-97.
64. VRDOLJAK E, MISE K, SAPUNAR D, ROZGA A, MARUSIC M. Survival analysis of untreated patients with non-small cell lung cancer. Chest 1994; 106: 1797-1800.
65. WALLACE JR, COHEN AMD, AWE RJ, GREENBERG D, HADLOCK F, PARK SK. Carcinomatous lung abscess. JAMA 1979; 242: 521-522.
66. WATKIN SW, HAYHURST GK, GREEN JA. Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region. Br J Cancer 1990; 61: 590-596.
67. WEDER W, SCHMIDT RA, BRUCHHAUS H, HILLINGER S, VON SCHULTHESS GK, STEINERT HC. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998; 66: 886-892.
68. WIGH R, GILMORE FR. Solitary pulmonary necrosis: a comparison of neoplastic and inflammatory conditions. Radiology 1951; 56: 708-716.
69. WOODRING JH. Unusal radiographic manifestation of lung cancer. Radiol Clin N Amer 1990; 28: 599-605.
70. YAMASHITA K, MATSUNOBE S, TSUDA T, OKUDA K, MATSUMOTO K, OYANAGI H, KONISHI J. Intratumoral necrosis of lung carcinoma: A potential diagnostic pitfall in incremental dynamic computed tomography analysis of solitary pulmonary nodule. J Thorac Imaging 1997; 12: 191-187.
71. ZORINI O. Primary carcinomatous cavities of the lung. Possible role of neoplastic cells autophagism. Dis Chest 1967; 52: 329-337.